Catecholaminergic Polymorphic Ventricular Tachycardia in a Patient With Recurrent Exertional Syncope |
Kim, Na-Young
(Department of Internal Medicine, Kyungpook National University School of Medicine)
Kang, Jung-Kyu (Department of Internal Medicine, Kyungpook National University School of Medicine) Park, Sun-Hee (Department of Internal Medicine, Kyungpook National University School of Medicine) Bae, Myung-Hwan (Department of Internal Medicine, Kyungpook National University School of Medicine) Lee, Jang-Hoon (Department of Internal Medicine, Kyungpook National University School of Medicine) Yang, Dong-Heon (Department of Internal Medicine, Kyungpook National University School of Medicine) Park, Hun-Sik (Department of Internal Medicine, Kyungpook National University School of Medicine) Chae, Shung-Chull (Department of Internal Medicine, Kyungpook National University School of Medicine) Jun, Jae-Eun (Department of Internal Medicine, Kyungpook National University School of Medicine) Cho, Yong-Keun (Department of Internal Medicine, Kyungpook National University School of Medicine) |
1 | Horner JM, Ackerman MJ. Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm 2008;5:1690-4. DOI ScienceOn |
2 | Krahn AD, Healey JS, Chauhan V, et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Circulation 2009;120: 278-85. DOI ScienceOn |
3 | George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003;93:531-40. DOI ScienceOn |
4 | Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74. DOI ScienceOn |
5 | Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-7. DOI ScienceOn |
6 | Nam GB, Burashnikov A, Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation 2005;111:2727-33. DOI ScienceOn |
7 | di Barletta MR, Viatchenko-Karpinski S, Nori A, et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006;114:1012-9. DOI ScienceOn |
8 | Maron BJ, Chaitmann BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109; 2807-16. DOI ScienceOn |
9 | Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119:2426-34. DOI ScienceOn |
10 | Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42:863-70. DOI |
11 | Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995;91:1512-9. DOI ScienceOn |
12 | Watanabe H, Chopra N, Laver D, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-3. DOI ScienceOn |
13 | Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008;358:2024-9. DOI ScienceOn |